U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 10 of 19 results

Status:
US Approved Rx (2018)
First approved in 1950

Class (Stereo):
CHEMICAL (ABSOLUTE)



Droxidopa (Northera, Chelsea Therapeutics) is a synthetic catecholamino acid precursor of norepinephrine indicated for the treatment of orthostatic dizziness or lightheadedness in adult patients with symptomatic neurogenic orthostatic hypotension (NO...
Status:
US Approved Rx (2021)
First approved in 1948

Class (Stereo):
CHEMICAL (RACEMIC)



Isoproterenol (trade names Medihaler-Iso and Isuprel) is a medication used for the treatment of bradycardia (slow heart rate), heart block, and rarely for asthma. Isoproterenol is a non-selective β adrenoreceptor agonist and TAAR1 agonist that is th...
Status:
US Approved OTC
First marketed in 1921

Class (Stereo):
CHEMICAL (ACHIRAL)



Diammonium carbonate is a salt with the chemical formula (NH4)2CO3. Since it readily degrades to gaseous ammonia and carbon dioxide upon heating, it is used as a leavening agent and also as smelling salt. Ammonium carbonate may be used as a leavening...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)



2-Iminobiotin (2-IB) is a cyclic guanidino analog of biotin (Vitamin B7) and combined neuronal and inducible (but not endothelial) nitric oxide synthase inhibitor that has been demonstrated to improve neuroprotection in animal models of hypoxic-ische...
Status:
Possibly Marketed Outside US
First approved in 2019

Class (Stereo):
CHEMICAL (ACHIRAL)



Dihydrocapsaicin is a capsaicinoid and analog and congener of capsaicin in chili peppers. Like capsaicin, it contributes to the spicy taste of chili peppers, although it is less potent than capsacian. Dihydrocapsaicin has been shown to induce hypothe...
Status:
US Approved Rx (2018)
First approved in 1950

Class (Stereo):
CHEMICAL (ABSOLUTE)



Droxidopa (Northera, Chelsea Therapeutics) is a synthetic catecholamino acid precursor of norepinephrine indicated for the treatment of orthostatic dizziness or lightheadedness in adult patients with symptomatic neurogenic orthostatic hypotension (NO...
Status:
US Approved Rx (2018)
First approved in 1950

Class (Stereo):
CHEMICAL (ABSOLUTE)



Droxidopa (Northera, Chelsea Therapeutics) is a synthetic catecholamino acid precursor of norepinephrine indicated for the treatment of orthostatic dizziness or lightheadedness in adult patients with symptomatic neurogenic orthostatic hypotension (NO...
Status:
US Approved Rx (2018)
First approved in 1950

Class (Stereo):
CHEMICAL (ABSOLUTE)



Droxidopa (Northera, Chelsea Therapeutics) is a synthetic catecholamino acid precursor of norepinephrine indicated for the treatment of orthostatic dizziness or lightheadedness in adult patients with symptomatic neurogenic orthostatic hypotension (NO...
Status:
US Approved Rx (2018)
First approved in 1950

Class (Stereo):
CHEMICAL (RACEMIC)



Droxidopa (Northera, Chelsea Therapeutics) is a synthetic catecholamino acid precursor of norepinephrine indicated for the treatment of orthostatic dizziness or lightheadedness in adult patients with symptomatic neurogenic orthostatic hypotension (NO...
Status:
US Approved Rx (2018)
First approved in 1950

Class (Stereo):
CHEMICAL (ABSOLUTE)



Droxidopa (Northera, Chelsea Therapeutics) is a synthetic catecholamino acid precursor of norepinephrine indicated for the treatment of orthostatic dizziness or lightheadedness in adult patients with symptomatic neurogenic orthostatic hypotension (NO...

Showing 1 - 10 of 19 results